Management of hypersensivity pneumonitis

Clinical and Translational Allergy

Volumn 3, Issue 1, 2013, Pages 1-10

  Agache, Ioana O ^a,b   Rogozea, Liliana ^b  

^a Theramed Medical Center   (Romania)

^b TRANSILVANIA UNIVERSITY OF BRASOV   (Romania)

Author keywords

Drug induced lung disease; Granulomatous inflammation; Hypersensitivity pneumonitis; Interstitial lung disease; Lung immune response

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; GAMMA INTERFERON; MACROLIDE; METHYLPREDNISOLONE; PENTOXIFYLLINE; REPARIXIN; THALIDOMIDE;

ALLERGIC PNEUMONITIS; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; COMPUTER ASSISTED TOMOGRAPHY; CYTOKINE PRODUCTION; DENDRITIC CELL; EARLY DIAGNOSIS; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; LUNG LAVAGE; LYMPHOCYTE PROLIFERATION; MEMORY T LYMPHOCYTE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SACCHAROPOLYSPORA RECTIVIRGULA;

EID: 85006289291     PISSN: None     EISSN: 20457022     Source Type: Journal    
DOI: 10.1186/2045-7022-3-5     Document Type: Article

References (117)

1. Patel AM, Ryu JH, Reed CE: Hypersensitivity pneumonitis: current concepts and future questions. J Allergy Clin Immunol. 2001, 108: 661-670. 10.1067/mai.2001.119570.
2. Cormier Y, Israël-Assayag E: The role of viruses in the pathogenesis of hypersensitivity pneumonitis. Curr Opin Pulm Med. 2000, 6: 420-423. 10.1097/00063198-200009000-00006.
3. Girard M, Israël-Assayag E, Cormier Y: Mature CD11c[+] cells are enhanced in hypersensitivity pneumonitis. Eur Respir J. 2009, 34: 749-756. 10.1183/09031936.00140908.
4. Barrera L, Mendoza F, Zuniga J: Functional diversity of T-­cell subpopulations in subacute and chronic hypersensitivity pneumonitis. Am J Respir Crit Care Med. 2008, 177: 44-55.
5. Mitaka K, Miyazaki Y, Yasui M: Th2-biased immune responses are important in a murine model of chronic hypersensitivity pneumonitis. Int Arch Allergy Immunol. 2011, 154: 264-274. 10.1159/000321114.
6. Metersky ML, Bean SB, Meyer JD: Trombone player’s lung: a probable new cause of hypersensitivity pneumonitis. Chest. 2010, 138: 754-756. 10.1378/chest.10-0374.
7. Morell F, Cruz MJ, Gómez FP: Chacinero’s lung - hypersensitivity pneumonitis due to dry sausage dust. Scand J Work Environ Health. 2011, 37: 349-356. 10.5271/sjweh.3151.
8. Otera H, Tada K, Sakurai T: Hypersensitivity pneumonitis associated with inhalation of catechin-rich green tea extracts. Respiration. 2011, 82: 388-392. 10.1159/000324450.
9. Koschel D, Stark W, Karmann F: Extrinsic allergic alveolitis caused by misting fountains. Respir Med. 2005, 99: 943-947. 10.1016/j.rmed.2005.01.004.
10. Ampere A, Delhaes L, Soots J, Bart F, Wallaert B: Hypersensitivity pneumonitis induced by Shiitake mushroom spores. Med Mycol. 2012, 50: 654-657. 10.3109/13693786.2012.658091.
11. Roshnee G, Cao GQ, Chen H: Hypersensitivity pneumonitis due to residential mosquito-coil smoke exposure. Chin Med J (Engl). 2011, 124: 1915-1918.
12. Toribio R, Cruz MJ, Morell F: Hypersensitivity pneumonitis related to medium-density fiberboard. Arch Bronconeumol. 2012, 48: 29-31.
13. Kupeli E, Karnak D, Sak SD: Hazards of the ‘hard cash’: hypersensitivity pneumonitis. Can Respir J. 2010, 17: e102-e105.
14. Usui K, Katou Y, Furushima K: Interstitial lung disease during chemotherapy combined with oxaliplatin and/or bevacizumab in advanced colorectal cancer patients. Jpn J Clin Oncol. 2011, 41: 498-502. 10.1093/jjco/hyr006.
15. Tonelli AR, Lottenberg R, Allan RW, Sriram PS: Rituximab-induced hypersensitivity pneumonitis. Respiration. 2009, 78: 225-229. 10.1159/000163069.
16. Martin N, Innes JA, Lambert CM: Hypersensitivity pneumonitis associated with leflunomide therapy. J Rheumatol. 2007, 34: 1934-1937.
17. Howard L, Gopalan D, Griffiths M: Sirolimus-induced pulmonary hypersensitivity associated with a CD4 T-cell infiltrate. Chest. 2006, 129: 1718-1721. 10.1378/chest.129.6.1718.
18. Alexandru S, Ortiz A, Baldovi S: Severe everolimus-associated pneumonitis in a renal transplant recipient. Nephrol Dial Transplant. 2008, 23: 3353-3355. 10.1093/ndt/gfn401.
19. Blanchet MR, Bennett JL, Gold MJ: CD34 is required for dendritic cell trafficking and pathology in murine hypersensitivity pneumonitis. Am J Respir Crit Care Med. 2011, 184: 687-698. 10.1164/rccm.201011-1764OC.
20. Reynolds SP, Jones KP, Edwards JH, Davies BH: Immunoregulatory proteins in bronchoalveolar lavage fluid. A comparative analysis of pigeon breeders’ disease, sarcoidosis and idiopathic pulmonary fibrosis. Sarcoidosis. 1989, 6: 125-134.
21. Dinarello CA: The many worlds of reducing interleukin­1. Arthritis Rheum. 2005, 52: 1960-1967. 10.1002/art.21107.
22. Nakae S, Asano M, Horai R, Iwakura Y: Interleukin­1 beta, but not interleukin-1 alpha, is required for T­cell-dependent antibody production. Immunology. 2001, 104: 402-409. 10.1046/j.1365-2567.2001.01337.x.
23. Ben-Sasson SZ, Hu-Li J, Quiel J: IL­1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation. Proc Natl Acad Sci USA. 2009, 106: 7119-7124. 10.1073/pnas.0902745106.
24. Israel-Assayag E, Dakhama A: Expression of costimulatory molecules on alveolar macrophages in hypersensitivity pneumonitis. Am J Respir Crit Care Med. 1999, 159: 1830-1834.
25. Israel-Assayag E, Fournier M, Cormier Y: Blockade of T cell costimulation by CTLA4-Ig inhibits lung inflammation in murine hypersensitivity pneumonitis. J Immunol. 1999, 163: 6794-6799.
26. Gudmundsson G, Hunninghake GW: Interferon-gamma is necessary for the expression of hypersensitivity pneumonitis. J Clin Invest. 1997, 99: 2386-2390. 10.1172/JCI119420.
27. Bhan U, Newstead MJ, Zeng X: Stachybotrys chartarum-induced hypersensitivity pneumonitis is TLR9 dependent. Am J Pathol. 2011, 179: 2779-2787. 10.1016/j.ajpath.2011.08.019.
28. Ye Q, Nakamura S, Sarria R: Interleukin 12, interleukin 18, and tumor necrosis factor alpha release by alveolar macrophages: acute and chronic hypersensitivity pneumonitis. Ann Allergy Asthma Immunol. 2009, 102: 149-154. 10.1016/S1081-1206(10)60246-3.
29. Simonian PL, Roark CL, Wehrmann F: Th17-polarized immune response in a murine model of hypersensitivity pneumonitis and lung fibrosis. J Immunol. 2009, 182: 657-665.
30. Joshi AD, Fong DJ, Oak SR: Interleukin-17-mediated immunopathogenesis in experimental hypersensitivity pneumonitis. Am J Respir Crit Care Med. 2009, 179: 705-716. 10.1164/rccm.200811-1700OC.
31. Bhan U, Newstead MJ, Zeng X: J TLR9-Dependent IL-23/IL-17 Is Required for the Generation of Stachybotrys chartarum-Induced Hypersensitivity Pneumonitis. Immunol. 2013, 190: 349-356. 10.4049/jimmunol.1202225.
32. Fong DJ, Hogaboam CM, Matsuno Y: Toll-like receptor 6 drives interleukin-17A expression during experimental hypersensitivity pneumonitis. Immunology. 2010, 130: 25-136.
33. Abdelsamed HA, Desai M, Nance SC: T-bet controls severity of hypersensitivity pneumonitis. J Inflamm. 2011, 8: 15-10.1186/1476-9255-8-15.
34. Simonian PL, Wehrmann F, Roark CL: γδ T cells protect against lung fibrosis via IL-22. J Exp Med. 2010, 207: 2239-2253. 10.1084/jem.20100061.
35. Simonian PL, Roark CL, Wehrmann F: IL-17A-expressing T cells are essential for bacterial clearance in a murine model of hypersensitivity pneumonitis. J Immunol. 2009, 182: 6540-6549. 10.4049/jimmunol.0900013.
36. Arikawa T, Saita N, Oomizu S: Galectin-9 expands immunosuppressive macrophages to ameliorate T-cell-mediated lung inflammation. Eur J Immunol. 2010, 40: 548-558. 10.1002/eji.200939886.
37. Park Y, Oh SJ, Chung DH: CD4 + CD25+ regulatory T cells attenuate hypersensitivity pneumonitis by suppressing IFN-γ production by CD4 + and CD8+ T cells. J Leukoc Biol. 2009, 86: 1427-1437. 10.1189/jlb.0908542.
38. Girard M, Israël-Assayag E, Cormier Y: Impaired function of regulatory T-cells in hypersensitivity pneumonitis. Eur Respir J. 2011, 37: 632-639. 10.1183/09031936.00055210.
39. Park HJ, Kim HS, Chung DH: Fcgamma receptors modulate pulmonary inflammation by activating innate immune cells in murine hypersensitivity pneumonitis. Immune Netw. 2010, 10: 26-34. 10.4110/in.2010.10.1.26.
40. Pardo A, Barrios R, Gaxiola M: Increase of lung neutrophils in hypersensitivity pneumonitis is associated with lung fibrosis. Am J Respir Crit Care Med. 2000, 161: 1698-1704.
41. Cui A, Anhenn O, Theegarten D: Angiogenic and angiostatic chemokines in idiopathic pulmonary fibrosis and granulomatous lung disease. Respiration. 2010, 80: 372-378. 10.1159/000245332.
42. Strieter RM, Belperio JA, Keane MP: CXC chemokines in angiogenesis related to pulmonary fibrosis. Chest. 2002, 122: 298-301S. 10.1378/chest.122.6_suppl.298S.
43. Hwang SJ, Kim HS, Chung DH: Fas/Fas ligand-mediated apoptosis promotes hypersensitivity pneumonitis in mice by enhancing maturation of dendritic cells. Am J Respir Crit Care Med. 2010, 181: 1250-1261. 10.1164/rccm.200909-1337OC.
44. Jinta T, Miyazaki Y, Kishi M: The pathogenesis of chronic hypersensitivity pneumonitis in common with idiopathic pulmonary fibrosis: Expression of apoptotic markers. Am J Clin Pathol. 2010, 134: 613-620. 10.1309/AJCPK8RPQX7TQRQC.
45. Fink JN, Ortega HG, Reynolds HY: NHLBI workshop: needs and opportunities for research in hypersensitivity pneumonitis. Am J Respir Crit Care Med. 2005, 171: 792-798. 10.1164/rccm.200409-1205WS.
46. Greinert U, Lepp U, Becker W: Bird keeper’s lung without bird keeping. Eur J Med Res. 2000, 27: 124-
47. Saltoun CA, Harris KE, Mathisen TL: Hypersensitivity pneumonitis resulting from community exposure to Canada goose droppings: when an external environmental antigen becomes an indoor environmental antigen. Ann Allergy Asthma Immunol. 2000, 84: 84-86. 10.1016/S1081-1206(10)62745-7.
48. Craig TJ, Hershey J, Engler RJ: Bird antigen persistence in the home environment after removal of the bird. Ann Allergy. 1992, 69: 510-512.
49. Curtis L, Lee BS, Cai D: Pigeon allergens in indoor environments: a preliminary study. Allergy. 2002, 57: 627-631. 10.1034/j.1398-9995.2002.03405.x.
50. Kuramochi J, Inase N, Takayama K: Detection of indoor and outdoor avian antigen in management of bird-related hypersensitivity pneumonitis. Allergol Int. 2010, 59: 223-228. 10.2332/allergolint.09-OA-0161.
51. McDevitt JJ, Lees PS, Merz WG: Development of a method to detect and quantify Aspergillus fumigatus conidia by quantitative PCR for environmental air samples. Mycopathologia. 2004, 158: 325-335. 10.1007/s11046-004-2304-8.
52. Rhodes G, Fluri A, Ruefenacht A: Implementation of a quantitative real-time PCR assay for the detection of Mycobacterium immunogenum in metalworking fluids. J Occup Environ Hyg. 2011, 8: 478-483. 10.1080/15459624.2011.590737.
53. Schäfer J, Kämpfer P, Jäckel U: Detection of Saccharopolyspora rectivirgula by quantitative real-time PCR. Ann Occup Hyg. 2011, 55: 612-619. 10.1093/annhyg/mer018.
54. Gbaguidi-Haore H, Roussel S, Reboux G: Multilevel analysis of the impact of environmental factors and agricultural practices on the concentration in hay of microorganisms responsible for farmer’s lung disease. Ann Agric Environ Med. 2009, 16: 219-225.
55. Silva CI, Churg A, Müller NL: Hypersensitivity pneumonitis: spectrum of high-resolution CT and pathologic findings. Am J Roentgenol. 2007, 188: 334-344. 10.2214/AJR.05.1826.
56. Lacasse Y, Selman M, Costabel U: Clinical diagnosis of hypersensitivity pneumonitis. Am J Respir Crit Care Med. 2003, 168: 952-958. 10.1164/rccm.200301-137OC.
57. Sennekamp J, Niese D, Stroehmann I: Pigeon breeders’ lung lacking detectable antibodies. Clin Allergy. 1978, 8: 305-310. 10.1111/j.1365-2222.1978.tb03228.x.
58. Rodrigo MJ, Postigo I, Wangensteen O: A new application of Streptavidin ImmunoCAP for measuring IgG antibodies against non-available commercial antigens. Clin Chim Acta. 2010, 411: 1675-1678. 10.1016/j.cca.2010.06.031.
59. Koschel D, Lützkendorf L, Wiedemann B: Antigen-specific IgG antibodies in feather duvet lung. Eur J Clin Investig. 2010, 40: 797-802. 10.1111/j.1365-2362.2010.02327.x.
60. Roussel S, Rognon B, Barrera C: Immuno-reactive proteins from Mycobacterium immunogenum useful for serodiagnosis of metalworking fluid hypersensitivity pneumonitis. Int J Med Microbiol. 2011, 301: 150-156. 10.1016/j.ijmm.2010.07.002.
61. Roussel S, Reboux G, Rognon B: Comparison of three antigenic extracts of Eurotium amstelodami in serological diagnosis of farmer’s lung disease. Clin Vaccine Immunol. 2010, 17: 160-167. 10.1128/CVI.00129-09.
62. Reboux G, Piarroux R, Mauny F: Role of molds in farmer’s lung disease in eastern France. Am J Respir Crit Care Med. 2001, 163: 1534-1539.
63. Inase N, Unoura K, Miyazaki Y: Measurement of bird specific antibody in bird-related hypersensitivity pneumonitis. Nihon Kokyuki Gakkai Zasshi. 2011, 49: 717-722.
64. Sterclova M, Vasakova M, Metlicka M: Significance of specific IgG against sensitizing antigens in extrinsic allergic alveolitis: serological methods in EAA. Rev Port Pneumol. 2011, 17: 253-259. 10.1016/j.rppneu.2011.07.001.
65. Fink JN, Schlueter DP, Sosman AJ: Clinical survey of pigeon breeders. Chest. 1972, 62: 277-281. 10.1378/chest.62.3.277.
66. Tillie-Leblond I, Grenouillet F, Reboux G: Hypersensitivity pneumonitis and metalworking fluids contaminated by mycobacteria. Eur Respir J. 2011, 37: 640-647. 10.1183/09031936.00195009.
67. Fenoglio CM, Reboux G, Sudre B: Diagnostic value of serum precipitins to mould antigens in active hypersensitivity pneumonitis. Eur Respir J. 2007, 29: 706-712. 10.1183/09031936.00001006.
68. Reboux G, Piarroux R, Roussel S: Assessment of four serological techniques in the immunological diagnosis of farmers’ lung disease. J Med Microbiol. 2007, 56: 1317-1321. 10.1099/jmm.0.46953-0.
69. Inase N, Sakashita H, Ohtani Y: Chronic bird fancier’s lung presenting with acute exacerbation due to use of a feather duvet. Intern Med. 2004, 43: 835-857. 10.2169/internalmedicine.43.835.
70. Cordeiro CR, Jones JC, Alfaro T: Bronchoalveolar lavage in occupational lung diseases. Semin Respir Crit Care Med. 2007, 28: 504-513. 10.1055/s-2007-991523.
71. Cormier Y, Letourneau L, Racine G: Significance of precipitins and asymptomatic lymphocytic alveolitis: a 20-yr follow-up. Eur Respir J. 2004, 23: 523-525. 10.1183/09031936.04.00021104.
72. Drent M, Wagenaar S, van Velzen-Blad H: Relationship between plasma cell levels and profile of bronchoalveolar lavage fluid in patients with subacute extrinsic allergic alveolitis. Thorax. 1993, 48: 835-839. 10.1136/thx.48.8.835.
73. Costabel U, Bross KJ, Ruhle KH: Ia-like antigens on T-cells and their subpopulations in pulmonary sarcoidosis and in hypersensitivity pneumonitis. Analysis of bronchoalveolar and blood lymphocytes. Am Rev Respir Dis. 1985, 131: 337-342.
74. Uzaslan E, Guzman J, Costabel U: Cockade-like structures in alveolar macrophages in extrinsic allergic alveolitis. Respiration. 2005, 72: 46-51. 10.1159/000083400.
75. Caillaud DM, Vergnon JM, Madroszyk A: Bronchoalveolar lavage in hypersensitivity pneumonitis: a series of 139 patients. Inflamm Allergy Drug Targets. 2012, 11: 15-19. 10.2174/187152812798889330.
76. Capelozzi VL, Faludi EP, Balthazar AB: Bronchoalveolar lavage improves diagnostic accuracy in patients with diffuse lung disease. Diagn Cytopathol. 2013, 41: 1-8. 10.1002/dc.21743.
77. Heron M, Claessen AM, Grutters JC: T-cell activation profiles in different granulomatous interstitial lung diseases-a role for CD8 + CD28[null] cells?. Clin Exp Immunol. 2010, 160: 256-265.
78. Unoura K, Miyazaki Y, Sumi Y: Identification of fungal DNA in BALF from patients with home-related hypersensitivity pneumonitis. Respir Med. 2011, 105: 1696-1703. 10.1016/j.rmed.2011.07.009.
79. Okamoto T, Miyazaki Y, Shirahama R: Proteome analysis of bronchoalveolar lavage fluid in chronic hypersensitivity pneumonitis. Allergol Int. 2012, 61: 83-92. 10.2332/allergolint.11-OA-0315.
80. Inase N, Ohtani Y, Sumi Y: A clinical study of hypersensitivity pneumonitis presumably caused by feather duvets. Ann Allergy Asthma Immunol. 2006, 96: 98-104. 10.1016/S1081-1206(10)61047-2.
81. Bouic PJ, Nel NC, Beer PM: In vitro reactivities of blood lymphocytes from symptomatic and asymptomatic pigeon breeders to antigen and mitogens. Int Arch Allergy Appl Immunol. 1989, 89: 222-228. 10.1159/000234950.
82. Hansen PJ, Penny R: Pigeon breeder’s disease: study of the cell-mediated immune response to pigeon antigens by the lymphocyte culture technique. Int Arch Allergy Appl Immunol. 1974, 47: 498-507. 10.1159/000231244.
83. Morell F, Roger A, Reyes L: Bird fancier’s lung: a series of 86 patients. Medicine [Baltimore]. 2008, 87: 110-130. 10.1097/MD.0b013e31816d1dda.
84. Ohtani Y, Kojima K, Sumi Y: Inhalation provocation tests in chronic bird fancier’s lung. Chest. 2000, 118: 1382-1389. 10.1378/chest.118.5.1382.
85. Myers JL: Hypersensitivity pneumonia: the role of lung biopsy in diagnosis and management. Mod Pathol. 2012, 25 (Suppl 1): S58-S67.
86. Hariri LP, Mino-Kenudson M, Shea B: Distinct histopathology of acute onset or abrupt exacerbation of hypersensitivity pneumonitis. Hum Pathol. 2012, 43: 660-668. 10.1016/j.humpath.2011.06.001.
87. Ohtani Y, Saiki S, Kitaichi M: Chronic bird fancier’s lung: histopathological and clinical correlation. An application of the 2002 ATS/ERS consensus classification of the idiopathic interstitial pneumonias. Thorax. 2005, 60: 665-671. 10.1136/thx.2004.027326.
88. Akashi T, Takemura T, Ando N: Histopathologic analysis of sixteen autopsy cases of chronic hypersensitivity pneumonitis and comparison with idiopathic pulmonary fibrosis/usual interstitial pneumonia. Am J Clin Pathol. 2009, 131: 405-415. 10.1309/AJCPNWX4SLZRP9SW.
89. Churg A, Wright JL, Tazelaar HD: Acute exacerbations of fibrotic interstitial lung disease. Histopathology. 2011, 58: 525-530. 10.1111/j.1365-2559.2010.03650.x.
90. León DE, Retana VN, Hernández-Pando R: Pigeon hypersensitivity pneumonitis: immunohistochemical demonstration of the causative antigen in the lung. Prim Care Respir J. 2007, 16: 252-256. 10.3132/pcrj.2007.00046.
91. Reghellin D, Poletti V, Tomassetti S: Cathepsin-K is a sensitive immunohistochemical marker for detection of micro-granulomas in hypersensitivity pneumonitis. Sarcoidosis Vasc Diffuse Lung Dis. 2010, 27: 57-63.
92. Shirai T, Ikeda M, Morita S: Elevated alveolar nitric oxide concentration after environmental challenge in hypersensitivity pneumonitis. Respirology. 2010, 15: 721-722. 10.1111/j.1440-1843.2010.01726.x.
93. Ishikawa N, Hattori N, Yokoyama A: Utility of KL-6/MUC1 in the clinical management of interstitial lung diseases. Respir Investig. 2012, 50: 3-13.
94. Inase N, Ohtani Y, Usui Y: Chronic summer-type hypersensitivity pneumonitis: clinical similarities to idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis. 2007, 24: 141-147.
95. Takao T, Hanehira T, Zenke Y: The sequential changes of the serum levels of KL-6, SP-D, and DLco were followed for a long term in a case of acute bird fancier’s lung. Aerugi. 2009, 58: 1433-1440.
96. Erkinjuntti-Pekkanen R, Kokkarinen JI, Tukiainen HO: Long-term outcome of pulmonary function in farmer’s lung: a 14 year follow-up with matched controls. Eur Respir J. 1997, 10: 2046-2050. 10.1183/09031936.97.10092046.
97. Kruit A, Gerritsen WB, Pot N: CA 15-3 as an alternative marker for KL-6 in fibrotic lung diseases. Sarcoidosis Vasc Diffuse Lung Dis. 2010, 27: 138-146.
98. Tateishi T, Ohtani Y, Takemura T: Serial high-resolution computed tomography findings of acute and chronic hypersensitivity pneumonitis induced by avian antigen. J Comput Assist Tomogr. 2011, 35: 272-279. 10.1097/RCT.0b013e318209c5a6.
99. Walsh SL, Sverzellati N, Devaraj A, Wells AU, Hansell DM: Chronic hypersensitivity pneumonitis: high resolution computed tomography patterns and pulmonary function indices as prognostic determinants. Eur Radiol. 2012, 22: 1672-1679. 10.1007/s00330-012-2427-0.
100. Koschel DS, Cardoso C, Wiedemann B: Pulmonary hypertension in chronic hypersensitivity pneumonitis. Lung. 2012, 190: 295-302. 10.1007/s00408-011-9361-9.
101. Miyazaki Y, Tateishi T, Akashi T: Clinical predictors and histologic appearance of acute exacerbations in chronic hypersensitivity pneumonitis. Chest. 2008, 134: 1265-1270. 10.1378/chest.08-0866.
102. Kuramochi J, Inase N, Miyazaki Y: Lung cancer in chronic hypersensitivity pneumonitis. Respiration. 2011, 82: 263-267. 10.1159/000327738.
103. Yoshizawa Y, Miyake S, Sumi Y: A follow-up study of pulmonary function tests, bronchoalveolar lavage cells, and humoral and cellular immunity in bird fancier’s lung. J Allergy Clin Immunol. 1995, 96: 122-129. 10.1016/S0091-6749(95)70041-2.
104. Buchvald F, Petersen BL, Damgaard K: Frequency, treatment, and functional outcome in children with hypersensitivity pneumonitis. Pediatr Pulmonol. 2011, 46: 1098-1107. 10.1002/ppul.21479.
105. Kokkarinen JI, Tukiainen HO, Terho EO: Effect of corticosteroid treatment on the recovery of pulmonary function in farmer’s lung. Am Rev Respir Dis. 1992, 145: 3-5. 10.1164/ajrccm/145.1.3.
106. Yoshizawa Y, Ohtani Y, Hayakawa H: Chronic hypersensitivity pneumonitis in Japan: a nationwide epidemiologic survey. J Allergy Clin Immunol. 1999, 103: 315-320. 10.1016/S0091-6749(99)70507-5.
107. Ye Q, Chen B, Tong Z: Thalidomide reduces IL-18, IL-8 and TNF-alpha release from alveolar macrophages in interstitial lung disease. Eur Respir J. 2006, 28: 824-831. 10.1183/09031936.06.00131505.
108. Tong Z, Chen B, Dai H: Extrinsic allergic alveolitis: inhibitory effects of pentoxifylline on cytokine production by alveolar macrophages. Ann Allergy Asthma Immunol. 2004, 92: 234-239. 10.1016/S1081-1206(10)61553-0.
109. Miyajima M, Suga M, Nakagawa K: Effects of erythromycin on experimental extrinsic allergic alveolitis. Clin Exp Allergy. 1999, 29: 253-261. 10.1046/j.1365-2222.1999.00430.x.
110. Losa García JE, Mateos Rodríguez F, Jiménez López A: Effect of cyclosporin A on inflammatory cytokine production by human alveolar macrophages. Respir Med. 1998, 92: 722-728. 10.1016/S0954-6111(98)90002-6.
111. Thornburg A, Abonour R, Smith P: Hypersensitivity pneumonitis-like syndrome associated with the use of lenalidomide. Chest. 2007, 131: 1572-1574. 10.1378/chest.06-1734.
112. Lerch E, Györik S, Feilchenfeldt J: A case of lenalidomide-induced hypersensitivity pneumonitis. Onkologie. 2010, 33: 249-252. 10.1159/000305213.
113. Chew GY, Hawkins CA, Cherian M: Roxithromycin induced hypersensitivity pneumonitis. Pathology. 2006, 38: 475-477. 10.1080/00313020600922348.
114. Roelofs PM, Klinkhamer PJ, Gooszen HC: Hypersensitivity pneumonitis probably caused by cyclosporine. A case report. Respir Med. 1998, 92: 1368-1370. 10.1016/S0954-6111(98)90144-5.
115. Jiménez-Alvarez L, Arreola JL, Ramírez-Martínez G:The effect of CTLA-4Ig, a CD28/B7 antagonist, on the lung inflammation and T cell subset profile during murine hypersensitivity pneumonitis. Exp Mol Pathol. 2011, 91: 718-22. 10.1016/j.yexmp.2011.09.010.
116. Casilli F, Bianchini A, Gloaguen I: Inhibition of interleukin-8 [CXCL8/IL-8] responses by repertaxin, a new inhibitor of the chemokine receptors CXCR1 and CXCR2. Biochem Pharmacol. 2005, 69: 385-394. 10.1016/j.bcp.2004.10.007.
117. Zarbock A, Allegretti M, Ley K: Therapeutic inhibition of CXCR2 by Reparixin attenuates acute lung injury in mice. Br J Pharmacol. 2008, 155: 357-364.